Atezolizumab,Cabozantinib
Roche
['solid tumor', 'rcc,(-irccs),(-srcc),(-urcc)']
 do not miss the results of the first ph iii trial in all solid tumors comparing pd-l1i/tki vs tki after failure of prior ici followed by a discussion by the one and only #rcc leading the way hall d1 11:30 #asco23 
Postdoctoral GU Oncology Research Fellow @DanaFarber | MD '2021, MSc '2019 @USJLiban 🏎️🎾📖